Mariam Aleissa | Infectious Diseases and Public Health | Best Researcher Award

Published on by Global Mechanics Awards

Best Researcher Award

Mariam Aleissa,
King Faisal Specialist Hospital & Research Centre, United States.

Mariam Aleissa is a researcher affiliated with King Faisal Specialist Hospital & Research Centre, contributing to the field of Infectious Diseases and Public Health. Her academic profile reflects research engagement, scientific publications, and contributions within healthcare-related research domains.
[1]

Mariam Aleissa
Affiliation King Faisal Specialist Hospital & Research Centre
Country United States
Scopus ID 57194947163
Documents 37
Citations 3,994 citations by 3,034 documents
h-index 11
Subject Area Infectious Diseases and Public Health
Event Global Mechanics Awards
ORCID 0000-0002-2355-4036

The Best Researcher Award profile recognizes academic professionals whose research activities demonstrate measurable contributions through scholarly communication, scientific collaboration, and advancement of knowledge in specialized disciplines.
[2]

Abstract

This article presents an academic recognition profile of Mariam Aleissa, highlighting her institutional affiliation, research activity, publication record, and scientific impact within Infectious Diseases and Public Health. The profile summarizes publicly available scholarly indicators associated with her research career.
[1]

Keywords

Infectious Diseases, Public Health, Clinical Research, Epidemiology, Healthcare Innovation, Medical Research, Scientific Publications.

Introduction

Research in infectious diseases and public health plays an important role in understanding disease patterns, improving healthcare strategies, and supporting evidence-based medical practices. Academic researchers contribute to these goals through clinical investigations, collaborative studies, and publication of scientific findings.
[3]

Research Profile

Mariam Aleissa’s research profile demonstrates involvement in infectious diseases and public health research. Her scholarly record includes documented publications and citation activity indexed through international academic databases.
[1]

Research Contributions

Her contributions are associated with healthcare research topics including disease prevention, medical analysis, and public health advancement. These activities support broader scientific understanding and interdisciplinary healthcare development.
[3]

Publications

The researcher has published academic works indexed in scholarly databases, with 37 documented publications and significant citation activity reflecting engagement with the scientific community.
[1]

Research Impact

Citation records and publication metrics provide indicators of research visibility. Her h-index and citation record demonstrate the reach of her scholarly contributions within relevant research areas.
[1]

Award Suitability

The Best Researcher Award recognizes researchers demonstrating academic productivity, scientific influence, and meaningful contributions to their respective fields. Mariam Aleissa’s research record aligns with evaluation criteria focused on scholarly achievement and impact.
[2]

Conclusion

Mariam Aleissa represents a research profile within Infectious Diseases and Public Health, supported by academic publications, citation indicators, and institutional research engagement. Her work contributes to ongoing scientific discussions in healthcare and medical research.

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Mariam Aleissa, Author ID 57194947163. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57194947163
  2. Global Mechanics Awards. (n.d.). Research Recognition and Award Information.

    Global Mechanics Awards


  3. World Health Organization. (n.d.). Public Health and Infectious Disease Research Resources.

    https://www.who.int/

Lisa Ford | Clinical Research | Best Researcher Award

Published on by Global Mechanics Awards

Dr. Lisa Ford | Clinical Research | Best Researcher Award

Executive Medical Director at Johnson and Johnson | United States

Dr. Lisa Melanie Ford, M.D., FAAN, stands as a distinguished physician, academician, and research leader whose career reflects an enduring dedication to advancing pediatric neurology and neuroscience innovation. Trained at Temple University School of Medicine and the Children’s Hospital Medical Center in Cincinnati, she cultivated deep expertise in child neurology, neonatology, and neurodevelopmental disorders. Her career bridges academic excellence and industry leadership, having served as Clinical Associate Professor of Neurosciences and Pediatrics at Rutgers University, while also directing and leading transformative clinical research initiatives at major pharmaceutical organizations including CIBA-GEIGY, Whitehall-Robins Healthcare, and Janssen Pharmaceuticals. Renowned for her contributions to the understanding and treatment of neurological and psychiatric disorders, Dr. Ford’s work has influenced both clinical practices and drug development strategies in pediatric and adult neurology. Her leadership at Janssen Neuroscience, where she serves as Senior Director of Research and Development and Clinical Development Team Leader, exemplifies her commitment to innovation, evidence-based medicine, and patient-centered care. Recognized by numerous national and international honors, Dr. Ford’s achievements include accolades from the American Academy of Neurology, Johnson & Johnson, and the Consumers Research Council of America, celebrating her as one of the nation’s top physicians. A Fellow of the American Academy of Neurology and the American Epilepsy Society, Dr. Ford continues to be a guiding force in translating scientific discovery into therapeutic progress. Her legacy reflects an inspiring blend of medical excellence, visionary leadership, and lifelong dedication to improving neurological health across generations.

Profile: Scopus

Featured Publications:

Authors not listed. (2025). A randomized, double-blind, placebo-controlled, time-to-event study of the efficacy and safety of JNJ-40411813 in combination with levetiracetam or brivaracetam in patients with focal onset seizures. Epilepsia.

Authors not listed. (2025). Brain MRI signatures across sex and CSF Alzheimer’s disease biomarkers. Brain Communications.

Authors not listed. (2024). Amyloid-PET imaging predicts functional decline in clinically normal individuals. Alzheimer’s Research & Therapy.